Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / March / Blood Test Forecasts Alzheimers Onset
Neurology Biochemistry and molecular biology Liquid biopsy Molecular Pathology Research and Innovations

Blood Test Forecasts Alzheimer's Onset

Plasma p-tau217 “clocks” estimate timing of symptoms years before clinical diagnosis

03/09/2026 News 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Share

Top Institutions in Neurology - Alzheimer's Disease Biomarkers

Leading institutions employ longitudinal cohort studies, advanced biomarker assays, and statistical modeling to develop predictive disease clocks integrating plasma p-tau217 levels with clinical and imaging data to forecast Alzheimer's symptom onset.

  • #100

    Washington University School of Medicine

    St. Louis, MO

    Pioneers in Alzheimer's biomarker research, particularly in plasma p-tau217, with extensive longitudinal cohorts and integration of fluid biomarkers and imaging modalities.

    Key Differentiators

    • Neurology
    • Alzheimer's Disease Research
    • Biomarker Development
  • #88

    Mayo Clinic

    Rochester, MN

    Extensive expertise in Alzheimer's disease biomarkers including tau PET imaging and plasma assays, with large well-characterized cohorts and advanced neuropathological correlation.

    Key Differentiators

    • Neurology
    • Neurodegenerative Disease
    • Biomarker Research
  • #85

    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Leaders in neuroimaging and biomarker integration, with significant contributions to understanding tau pathology and its clinical implications using PET and fluid biomarkers.

    Key Differentiators

    • Neurology
    • Alzheimer's Disease
    • Neuroimaging
  • #80

    University of California, San Francisco (UCSF)

    San Francisco, CA

    Known for innovative biomarker research and clinical trials focused on early detection and progression of Alzheimer's disease using fluid and imaging markers.

    Key Differentiators

    • Neurology
    • Alzheimer's Disease
    • Biomarker Development
  • #75

    University of Pennsylvania Perelman School of Medicine

    Philadelphia, PA

    Noted for biomarker discovery and validation in Alzheimer's disease, including plasma tau assays and multimodal approaches combining imaging and fluid biomarkers.

    Key Differentiators

    • Neurology
    • Neurodegenerative Diseases
    • Biomarker Research

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

A Light in the Darkness
Liquid biopsy
A Light in the Darkness

March 4, 2022

2 min read

Spectroscopic liquid biopsy testing – a new route to brain cancer diagnostics

Biomarkers: The Bigger Picture
Liquid biopsy
Biomarkers: The Bigger Picture

April 27, 2022

1 min read

To unlock patient care, pathologists must focus on molecular pathology and ensure efficiency and effectiveness to improve testing. With this testing, patients can benefit from the best treatment to combat their disease.

Benchmarking… Liquid Biopsy
Liquid biopsy
Benchmarking… Liquid Biopsy

May 13, 2022

1 min read

A look at the last five years of publishing on liquid biopsy

Does Your Blood Know You Have Cancer?
Liquid biopsy
Does Your Blood Know You Have Cancer?

July 25, 2022

2 min read

Detection and monitoring are crucial for melanoma outcomes – could a blood test revolutionize both?

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.